EBS
Emergent Biosolutions Inc
6.80$
+0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +359.4% | -109.6% | – | -86.8% | +317.0% | +226.3% | -85.3% | +171.7% | +144.6% | +15.8% | -60.4% | +20.3% | +289.1% | -79.9% | +349.8% | +185.6% | -40.2% | -110.6% | – | – | +190.6% | |
| – | +90.1% | +32.9% | +2.2% | +3.1% | +0.7% | +19.8% | +56.2% | +19.7% | +69.3% | +71.2% | +8.9% | +8.2% | +11.4% | +46.1% | +78.0% | +3.4% | +8.1% | +15.8% | -12.7% | -13.0% | -11.9% | |
| – | +10,849.4% | -97.3% | -96.7% | +10,358.3% | +99.5% | +41.1% | +52.0% | +3.5% | +1.1% | +14.2% | +23.5% | +16.6% | -17.7% | +52.5% | +15.1% | +94.0% | -18.1% | +6.4% | -48.8% | -22.1% | -10.0% | |
| – | – | – | – | – | – | – | – | +466.5% | +184.0% | +21.3% | -18.0% | -60.8% | +227.5% | +23.1% | +72.8% | +67.4% | +14.0% | -64.8% | – | – | – | |
| – | – | -552.3% | – | -183.7% | – | – | -312.5% | – | – | -43.9% | -586.7% | – | – | -321.7% | – | – | -1,746.3% | – | – | – | -125.3% | |
| – | -61.7% | +531.2% | +6.6% | -52.7% | +59.9% | -33.6% | +144.5% | -0.3% | -22.0% | -27.0% | +46.1% | +70.2% | -28.1% | +31.5% | +20.5% | +63.3% | +58.6% | -48.5% | -55.4% | -55.6% | -39.7% | |
| – | -67.9% | +612.9% | +5.6% | -29.9% | +8.0% | -29.5% | +130.1% | -25.7% | +69.3% | +209.4% | -78.4% | +67.7% | +227.7% | +259.0% | -89.2% | +56.8% | +48.1% | +69.5% | – | -41.0% | -44.6% | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | +2,125.0% | -10.7% | – | – | – | – | |
| – | -49.3% | -43.0% | – | – | – | – | -100.0% | – | -96.4% | -6.1% | -50.0% | +1,000.0% | +2,909.1% | -99.7% | +7,300.0% | +86.5% | +668.1% | -22.5% | +0.0% | – | -202.9% | |
| – | – | – | – | – | – | – | – | – | – | – | -98.9% | -1,100.0% | +12.3% | – | -98.3% | +297.8% | -165.9% | – | -196.3% | -63.5% | -45.2% | |
| – | -176.7% | – | -78.5% | -51.5% | +65.5% | -163.0% | – | -112.4% | – | +2,209.3% | -83.2% | -155.7% | +175.7% | – | -104.6% | – | -302.9% | – | -211.3% | -64.5% | -28.1% | |
| – | – | +36.1% | -26.9% | -148.6% | – | +477.2% | -138.0% | – | – | +168.5% | -68.1% | -227.8% | – | – | – | +715.6% | -110.0% | – | -900.8% | – | – | |
| – | – | -226.8% | – | -217.6% | – | – | -150.9% | – | – | +48.6% | -100.4% | – | – | -119.8% | – | +290.7% | -75.7% | -256.0% | – | – | +338.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.